Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2026-03-09 @ 1:59 AM
Study NCT ID:
NCT00034593
Status:
COMPLETED
Last Update Posted:
2006-07-19
First Post:
2002-04-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Sponsor:
Eli Lilly and Company
Organization: